表皮生长因子基因多态性与膀胱癌的相关性研究

程佳颖, 岳根全, 赵灵燕, 等. 表皮生长因子基因多态性与膀胱癌的相关性研究[J]. 临床泌尿外科杂志, 2021, 36(8): 607-611. doi: 10.13201/j.issn.1001-1420.2021.08.004
引用本文: 程佳颖, 岳根全, 赵灵燕, 等. 表皮生长因子基因多态性与膀胱癌的相关性研究[J]. 临床泌尿外科杂志, 2021, 36(8): 607-611. doi: 10.13201/j.issn.1001-1420.2021.08.004
CHENG Jiaying, YUE Genquan, ZHAO Lingyan, et al. Study on the relationship between bladder cancer and epidermal growth factor gene polymorphism[J]. J Clin Urol, 2021, 36(8): 607-611. doi: 10.13201/j.issn.1001-1420.2021.08.004
Citation: CHENG Jiaying, YUE Genquan, ZHAO Lingyan, et al. Study on the relationship between bladder cancer and epidermal growth factor gene polymorphism[J]. J Clin Urol, 2021, 36(8): 607-611. doi: 10.13201/j.issn.1001-1420.2021.08.004

表皮生长因子基因多态性与膀胱癌的相关性研究

详细信息
    通讯作者: 高玉敏,E-mail:gaoyumin0712@163.com
  • 中图分类号: R737.14

Study on the relationship between bladder cancer and epidermal growth factor gene polymorphism

More Information
  • 目的:探讨表皮生长因子(EGF)基因多态性与膀胱癌易感性的关系。方法:采用以医院为基础的1:1配对病例对照研究,共纳入190例膀胱癌患者作为病例组,同时选取同性别、年龄(±5岁)与病例匹配的190例健康个体为对照组。通过问卷调查收集研究对象一般情况及生活习惯,采用多重高温连接酶检测反应技术进行基因分型,比较两组基因型分布和等位基因频率,采用条件logistics回归法进行统计分析,分析EGF基因多态性及环境因素与膀胱癌易感性的关系。结果:两组人群的基因型及等位基因频率分布差异无统计学意义(P>0.05)。不同基因型的人群发生膀胱癌的风险差异无统计学意义(P>0.05)。结论:吸烟和憋尿是膀胱癌发生的危险因素,吃水果和饮用纯净水是膀胱癌的保护因素。EGF rs2302135 AG基因型可能是膀胱癌的保护基因型。
  • 加载中
  • [1]

    Ferlay J,Colombet M,Soerjomataram I,et al.Estimating the global cancer incidence and mortality in 2018:GLOBOCAN sources and methods[J].Int J Cancer,2019,144(8):1941-1953.

    [2]

    毕海,覃子健,刘承,等.淋巴细胞/单核细胞比值对根治性膀胱全切患者生存预后的预测价值[J].临床泌尿外科杂志,2021,36(5):342-347.

    [3]

    Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.

    [4]

    Ploeg M,Aben KK,Kiemeney LA.The present and future burden of urinary bladder cancer in the world[J].World J Urol,2009,27(3):289-293.

    [5]

    van Rhijn BW,Burger M,Lotan Y,et al.Recurrence and progression of disease in non-muscle-invasive bladder cancer:from epidemiology to treatment strategy[J].Eur Urol,2009,56(3):430-442.

    [6]

    Wu X,Hildebrandt MA,Chang DW.Genome-wide association studies of bladder cancer risk:a field synopsis of progress and potential applications[J].Cancer Metastasis Rev,2009,28(3-4):269-280.

    [7]

    Dreux AC,Lamb DJ,Modjtahedi H,et al.The epidermal growth factor receptors and their family of ligands:their putative role in atherogenesis[J].Atherosclerosis,2006,186(1):38-53.

    [8]

    Harris RC,Chung E,Coffey RJ.EGF receptor ligands[J].Exp Cell Res,2003,284(1):2-13.

    [9]

    Mazzoleni S,Politi LS,Pala M,et al.Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis[J].Cancer Res,2010,70(19):7500-7513.

    [10]

    Normanno N,De Luca A,Bianco C,et al.Epidermal growth factor receptor(EGFR)signaling in cancer[J].Gene,2006,366(1):2-16.

    [11]

    谭倩,赵鑫,陈贝,等.生长因子在创面愈合中的作用研究进展[J].山东医药,2019,59(4):106-110.

    [12]

    Mullhaupt B,Feren A,Jones A,et al.DNA sequence and functional characterization of the human and rat epidermal growth factor promoter:regulation by cell growth[J].Gene,2000,250(1-2):191-200.

    [13]

    Garcia R,Franklin RA,McCubrey JA.EGF induces cell motility and multi-drug resistance gene expression in breast cancer cells[J].Cell Cycle,2006,5(23):2820-2826.

    [14]

    Van Batavia J,Yamany T,Molotkov A,et al.Bladder cancers arise from distinct urothelial sub-populations[J].Nat Cell Biol,2014,16(10):982-91,1-5.

    [15]

    Babjuk M,Böhle A,Burger M,et al.EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder:Update 2016[J].Eur Urol,2017,71(3):447-461.

    [16]

    Burger M,Catto JWF,Dalbagni G,et al.Epidemiology and risk factors of urothelial bladder cancer[J].Eur Urol,2013,63(2):234-241.

    [17]

    Freedman ND,Silverman DT,Hollenbeck AR,et al.Association between smoking and risk of bladder cancer among men and women[J].JAMA,2011,306(7):737-745.

    [18]

    任维果.40岁以下膀胱癌相关因素的病例对照研究[D].山东:山东省医学科学院,2007.

    [19]

    彭吕杨.七种水果提取物抗氧化和抑制肿瘤活性研究[D].天津:天津大学,2014.

    [20]

    乌日丽其,宋华,李左军,等.结直肠癌患病饮食相关危险因素病例对照研究[J].疾病监测与控制,2016,10(1):70-72.

    [21]

    何大莉,曾照芳.EGF 61A/G基因多态性与黑色素瘤易感性关系的Meta分析[J].激光杂志,2013,34(4):110-111.

    [22]

    王明珠,谭诗云,郭芳,等.表皮细胞生长因子61 A/G基因多态性与胃癌易感性的Meta分析[J].中国医药导报,2015,12(20):85-88.

    [23]

    Costa BM,Ferreira P,Costa S,et al.Association between functional EGF+61 polymorphism and glioma risk[J].Clin Cancer Res,2007,13(9):2621-2626.

    [24]

    吴国洋,Michael Keese,Till Hasenberg,等.EGF基因多态性与结直肠癌的关系[J].中华普通外科杂志,2005,20(11):738-739.

    [25]

    Chen K,Wei Y,Yang H,et al.Epidermal growth factor +61 G/A polymorphism and the risk of hepatocellular carcinoma in a Chinese population[J].Genet Test Mol Biomarkers,2011,15(4):251-255.

    [26]

    Qi P,Wang H,Chen YM,et al.No association of EGF 5'UTR variant A61G and hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection[J].Pathology,2009,41(6):555-560.

  • 加载中
计量
  • 文章访问数:  542
  • PDF下载数:  67
  • 施引文献:  0
出版历程
收稿日期:  2021-01-02

目录